AbCellera Biologics Inc. (ABCL) Insider Trading -- Recent Executive & Director Transactions

4 insiders reported 14 Form 4 transactions for AbCellera Biologics Inc. (ABCL) over the past 18 months (most recent 2026-08-18). Recent activity: Montalbano John S. (Director) Buy 10,000 shares, Hayden Michael R (Director) Buy 46,387 shares, Booth Andrew (Chief Financial Officer) Buy 37,200 shares, Hayden Michael R (Director) Sell 50,000 shares, Booth Andrew (Chief Financial Officer) Buy 250,000 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-08-18Montalbano John S.DirectorBuy10,000$110,300
2026-08-14Hayden Michael RDirectorBuy46,387$481,033
2026-08-14Booth AndrewChief Financial OfficerBuy37,200$383,904
2026-08-13Hayden Michael RDirectorSell50,000$0
2026-06-03Booth AndrewChief Financial OfficerBuy250,000$47,500
2026-05-18Montalbano John S.DirectorBuy20,000$95,400
2026-03-02Thermopylae Holdings Ltd.InsiderBuy38,000$130,720
2026-02-27Booth AndrewChief Financial OfficerBuy42,600$145,692
2026-02-27Thermopylae Holdings Ltd.InsiderBuy177,457$580,284
2025-12-19Thermopylae Holdings Ltd.InsiderSell225,000$0
2025-11-26Montalbano John S.DirectorBuy50,000$178,500
2025-03-11Thermopylae Holdings Ltd.InsiderBuy343,631$742,243
2025-03-10Montalbano John S.DirectorBuy25,000$57,500
2025-03-07Montalbano John S.DirectorBuy60,000$140,400

Source: SEC Form 4 filings · as of 2026-08-18